The JAK2V617F mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burden
Date
2023-11
Journal Title
Journal ISSN
Volume Title
Publisher
Citation
Orbell, L Y, Abutheraa, N, Duncombe, A S, McMullin, M F, Mesa, R, McShane, C, James, G & Anderson, L 2023, 'The JAK2V617F mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burden', European Journal of Haematology, vol. 4, no. 4, pp. 1071-1080. https://doi.org/10.1002/jha2.805